Report cover image

Medical Marijuana

Publisher Global Industry Analysts
Published Jun 01, 2025
Length 193 Pages
SKU # GJOB20096149

Description

Global Medical Marijuana Market to Reach US$92.4 Billion by 2030

The global market for Medical Marijuana estimated at US$41.3 Billion in the year 2024, is expected to reach US$92.4 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Extract Form, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$60.5 Billion by the end of the analysis period. Growth in the Dried Flower segment is estimated at 13.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 13.6% CAGR

The Medical Marijuana market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$14.1 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.7% and 12.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR.

Global Medical Marijuana Market - Key Trends & Drivers Summarized

What Is Medical Marijuana and How Is It Used in Healthcare?

Medical marijuana refers to the use of cannabis and its cannabinoids, such as THC (tetrahydrocannabinol) and CBD (cannabidiol), to treat various medical conditions. It has been recognized for its therapeutic potential in managing chronic pain, epilepsy, multiple sclerosis, nausea associated with chemotherapy, and certain mental health conditions such as anxiety and PTSD. The cannabis plant contains active compounds that interact with the body’s endocannabinoid system to regulate pain, mood, and immune response. Medical marijuana is prescribed in various forms, including oils, tinctures, capsules, edibles, and vaporized products, providing healthcare providers and patients with multiple options for symptom management. As legalization efforts continue to expand, more regions are recognizing the value of medical marijuana in alleviating symptoms and improving patients’ quality of life, particularly for those with conditions that have not responded well to conventional treatments.

How Are Technological Advancements Transforming the Medical Marijuana Industry?

Technological advancements are significantly transforming the medical marijuana industry by improving cultivation, extraction, and delivery methods. Innovations in agricultural technologies, such as hydroponics and controlled-environment agriculture, allow for the precise cultivation of cannabis plants under optimal conditions, enhancing both the quality and consistency of the active compounds. Additionally, advancements in extraction techniques, such as CO2 extraction, have improved the purity and potency of medical cannabis products, ensuring that patients receive consistent and effective dosages. In terms of delivery, new technologies such as nanotechnology and encapsulation are being explored to improve the bioavailability of cannabis compounds, allowing for faster absorption and more targeted effects. These advancements not only improve patient outcomes but also enhance the safety and regulation of medical marijuana products, ensuring they meet stringent medical standards and regulatory requirements.

What Regulatory and Social Challenges Impact the Medical Marijuana Market?

The medical marijuana market is shaped by a complex regulatory landscape that varies widely between countries and even within states or regions of the same country. While many regions have legalized medical marijuana, the regulatory framework surrounding its cultivation, distribution, and use is often restrictive, requiring rigorous licensing processes, testing, and quality control measures to ensure safety and efficacy. Additionally, medical marijuana continues to face social stigma, despite growing evidence of its therapeutic benefits. Many patients and healthcare providers are still hesitant to adopt cannabis-based treatments due to concerns about legality, side effects, and the potential for misuse. However, as research continues to support the medical benefits of cannabis, public perception is slowly shifting, and healthcare providers are becoming more open to its integration into patient care plans. Addressing these regulatory and social challenges is critical to the sustained growth and acceptance of medical marijuana in mainstream healthcare.

Growth in the Medical Marijuana Market Is Driven by Several Factors

The growth in the medical marijuana market is driven by several factors, including the increasing legalization of cannabis for medical purposes in various regions. As more countries and states recognize the therapeutic potential of cannabis, the market expands, driven by increased access to legal products. Technological advancements in cultivation, extraction, and product formulation have also contributed to market growth, as they lead to higher-quality and more effective medical marijuana products. The rising prevalence of chronic diseases, particularly pain-related conditions, cancer, and neurological disorders, further fuels demand for medical marijuana as an alternative to traditional pharmaceuticals. Additionally, growing patient awareness and acceptance of cannabis-based treatments, coupled with the diminishing social stigma, are propelling the market forward. Regulatory reforms that streamline the approval and distribution process for medical cannabis products also play a significant role in expanding market opportunities globally, ensuring continued growth and innovation in the medical marijuana sector.

SCOPE OF STUDY:

The report analyzes the Medical Marijuana market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Extract Form, Dried Flower); End-Use (Pain Management, Seizures, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -
  • ABcann Medicinals, Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corporation
  • Emerald Health Therapeutics Inc.
  • Green Relief Inc.
  • GW Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Maricann Group, Inc.
  • mCig, Inc.
  • Medical Marijuana, Inc.
  • The Cronos Group Inc.
  • The Supreme Cannabis Company
  • Tilray
  • United Cannabis
AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

193 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Medical Marijuana – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Legalization Efforts Propel Market Growth for Medical Marijuana
Increasing Clinical Research Validates Therapeutic Benefits and Spurs Demand
Expanding Use in Chronic Pain Management Enhances Patient Access to Medical Marijuana
Technological Innovations in Cultivation and Extraction Methods Drive Product Quality
Growing Patient Advocacy and Awareness Expand Market Acceptance
Regulatory Advances in Cannabis Legislation Strengthen Market Opportunities
Increasing Use in Mental Health Treatment for Disorders Such as PTSD and Anxiety
Integration of Blockchain for Seed-to-Sale Tracking Boosts Transparency and Compliance
Rising Demand for Non-smokable Forms Such as Edibles and Oils Expands Consumer Base
Growing Elderly Population Adopts Medical Marijuana for Age-Related Conditions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Medical Marijuana Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Extract Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Extract Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Dried Flower by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Dried Flower by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Seizures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Seizures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 14: USA Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 15: USA 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 16: USA Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 17: USA 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
CANADA
TABLE 18: Canada Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 19: Canada 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 20: Canada Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: Canada 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
JAPAN
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 22: Japan Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 23: Japan 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 24: Japan Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 25: Japan 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
CHINA
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 26: China Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: China 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 28: China Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 29: China 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
EUROPE
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 30: Europe Recent Past, Current & Future Analysis for Medical Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 31: Europe 6-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 32: Europe Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Europe 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 34: Europe Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: Europe 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
FRANCE
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 36: France Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 37: France 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 38: France Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: France 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
GERMANY
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 40: Germany Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: Germany 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 42: Germany Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: Germany 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
ITALY
TABLE 44: Italy Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Italy 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 46: Italy Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: Italy 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
UNITED KINGDOM
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 48: UK Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: UK 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 50: UK Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: UK 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
REST OF EUROPE
TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: Rest of Europe 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 55: Rest of Europe 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
ASIA-PACIFIC
Medical Marijuana Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Asia-Pacific 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: Asia-Pacific 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
REST OF WORLD
TABLE 60: Rest of World Recent Past, Current & Future Analysis for Medical Marijuana by Type - Extract Form and Dried Flower - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Rest of World 6-Year Perspective for Medical Marijuana by Type - Percentage Breakdown of Value Sales for Extract Form and Dried Flower for the Years 2025 & 2030
TABLE 62: Rest of World Recent Past, Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Seizures and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Rest of World 6-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Seizures and Other End-Uses for the Years 2025 & 2030
IV. COMPETITION

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us